Covington Capital Management Ensysce Biosciences, Inc. Transaction History

Covington Capital Management

  • $23.2 Billion
  • Q3 2022

A detailed history of Covington Capital Management transactions in Ensysce Biosciences, Inc. stock. As of the latest transaction made, Covington Capital Management holds 100 shares of ENSC stock, worth $51. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 100 -0.0%
Holding current value
$51
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
BUY
N/A
100 New
100 $0
Q4 2021

Feb 16, 2022
SELL
N/A
-4,800 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
N/A
4,800 New
4,800 $15,000

Others Institutions Holding ENSC

# of Institutions
2
Shares Held
120
Call Options Held
0
Put Options Held
0
View Full List

About Ensysce Biosciences, Inc.

ENSC Quotes by TradingView
  • Ticker ENSC
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,918,900
  • Market Cap $979K
  • Description
  • Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abu...
More about ENSC
Track This Portfolio

Track Covington Capital Management Portfolio

Follow Covington Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covington Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Covington Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email